Skip to main content
. 2017 Jan 19;140:76–82. doi: 10.1016/j.antiviral.2017.01.012

Fig. 3.

Fig. 3

rpIFN-L1 and rpIFN-L3 inhibited G2 PEDV LNCT2 infection in IPEC-J2 cells. IPEC-J2 cells were pre-treated with rpIFN-L1 or rpIFN-L3 at indicated concentrations for 24 h in 24-well plates and then were infected with PEDV (LNCT2). Cells were further cultured for another 36 h prior to PEDV RNA quantification by RT-qPCR. The results are presented as the mean ± SEM (N = 3). *P < 0.05; **P < 0.01.